The 21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) took place in Boston, USA, 3rd-6th March 2014.

Conference highlights

Treatment as prevention

No-one with an undetectable viral load, gay or heterosexual, transmits HIV in two years of PARTNER study.

Conference news

All our news reporting on the research presented at the conference.

Injectable PrEP

Monkey studies confirm viability of injectable HIV pre-exposure prophylaxis (PrEP) drug.

Hep C treatment

Six-week oral treatment can cure hard-to-treat hepatitis C patients.

Maternal deaths

Maternal deaths due to HIV not declining despite PMTCT successes in South Africa.

HIV and HCV co-infection

Faldaprevir plus interferon and ribavirin cures hepatitis C in most people with HIV/HCV co-infection.

Conference bulletins

We published four free conference bulletins, in English, French, Italian, Spanish, Portuguese and Russian.

First-line HIV treatment

New NNRTI doravirine matches efavirenz for first-line HIV treatment.

News feeds and social media

Find out more about sharing news reports with your networks.

aidsmap news from CROI 2014

← First12Next →

Editors' picks from other sources

Email bulletins

Sign up for our regular email bulletins

Find out more and sign up to the full range of aidsmap email bulletins >

Official conference website

Find out more about the conference and view the program on the official conference website.

Visit the official CROI website >

aidsmap news apps

Keep up to date with the latest HIV news using the free aidsmap news apps for android and iPhone.

Download the app >
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.